OrbiMed Israel BioFund GP Limited Partnership

USReporting entityDirector

Transactions

Issuers

Buys / Sells

9/7

Last tx

03 Jan 2023

Behaviour

1 purchase reported after at least 12 months of silence — most recent on 28 Jul 2021.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Monster Digital, Inc.	8,565,974	reported	25 Jun 2021	tx 16+28,045,837−17,218,646
BiomX Inc.	2,813,489	reported	28 Jul 2021	tx 4+883,800
Chemomab Therapeutics Ltd.	2,311,798	reported	03 Jan 2023	tx 2−336,900
Eledon Pharmaceuticals, Inc.	0	reported	14 Jan 2020	tx 6+5,768,130

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
03 Jan 2023	SALE	Chemomab Therapeutics Ltd.	70,524	4.51 USD
03 Jan 2023	SALE	Chemomab Therapeutics Ltd.	266,376	3.34 USD
28 Jul 2021	PURCHASE	BiomX Inc.	500,000	—	first after silence
28 Jul 2021	PURCHASE	BiomX Inc.	375,000	—	deriv

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Monster Digital, Inc.	8,565,974	reported	25 Jun 2021	tx 16+28,045,837−17,218,646
BiomX Inc.	2,813,489	reported	28 Jul 2021	tx 4+883,800
Chemomab Therapeutics Ltd.	2,311,798	reported	03 Jan 2023	tx 2−336,900
Eledon Pharmaceuticals, Inc.	0	reported	14 Jan 2020	tx 6+5,768,130

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
03 Jan 2023	SALE	Chemomab Therapeutics Ltd.	70,524	4.51 USD
03 Jan 2023	SALE	Chemomab Therapeutics Ltd.	266,376	3.34 USD
28 Jul 2021	PURCHASE	BiomX Inc.	500,000	—	first after silence
28 Jul 2021	PURCHASE	BiomX Inc.	375,000	—	deriv